Sort
21,281 grants matching “influenza”
Toward a universal influenza virus vaccine based on live attenuated NS1-deleted influenza viruses
$1,126,946Adolfo Garcia-Sastre · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · AI
Toward a universal influenza virus vaccine based on live attenuated NS1-deleted influenza viruses
$1,126,946Adolfo Garcia-Sastre · Icahn School Of Medicine At Mount Sinai · R01 · FY2022 · AI
Immunobiology of Influenza Virus-related Critical Illness in Young Hosts
$1,126,202Adrienne G Randolph · Boston Children'S Hospital · R01 · FY2024 · AI
Leukotriene modifying agents in the prevention of excess morbidity and mortality from influenza
$1,126,149Tina V Hartert · Vanderbilt University Medical Center · R01 · FY2018 · AI
Structure-Guided Design of CD4 T cell Memory-Enhanced rHA H7N9 Influenza Vaccine
$1,123,469Anne Searls De Groot · Epivax, Inc. · R01 · FY2021 · AI
IDENTIFICATION AND CHARACTERIZATION OF T CELL EPITOPES FROM BACTERIAL PATHOGENS CAUSING PNEUMONIA
$1,123,365Bjoern Peters · La Jolla Institute For Immunology · N01 · FY2024 · AI
Micro-Particle Delivery of a Potent Intracellular Adjuvant for a Universal Flu Vaccine
$1,123,350Jenny P.y. Ting · Univ Of North Carolina Chapel Hill · R01 · FY2021 · AI
Facility Management, Maintenance and Operations Core
$1,123,307George Parsons Langan · University Of Chicago · UC7 · FY2025 · AI
Advancing a broad-spectrum anti-influenza A virus RNA packaging inhibitor to an IND
$1,121,874Jeffrey S Glenn · Stanford University · R01 · FY2019 · AI
Development of a Universal Influenza Vaccine
$1,121,460Frank R. Jones · Etubics Corporation · R01 · FY2015 · AI
Using a tonsil organoid system to probe conditions for the induction of protective antibody and T cell responses to influenza.
$1,121,263Mark M Davis · Stanford University · U19 · FY2019 · AI
Developing Teixobactin for Respiratory Infections
$1,120,776Dallas Hughes · Novobiotic Pharmaceuticals, Llc · R01 · FY2025 · AI
Alterations In Pulmonary Immune Function And Host Resistance In COX Null Mice
$1,120,676Darryl C Zeldin · National Institute Of Environmental Health Sciences · ZIA · FY2025 · ES
Broad Spectrum Neutralizing Human Abs to SARS and Related Coronaviruses
$1,117,743Wayne A. Marasco · Dana-Farber Cancer Inst · R01 · FY2011 · AI
Kaiser Washington Vaccine and Treatment Evaluation Unit
$1,117,166Lisa A Jackson · Kaiser Foundation Research Institute · UM1 · FY2021 · AI
RESPIRATORY PATHOGENS RESEARCH CENTERS (RPRC)
$1,116,944David Topham · University Of Rochester · N01 · FY2016 · AI
LINKING ASSESSMENT AND MEASUREMENT TO PERFORMANCE IN PHEP SYSTEMS (LAMPS)
$1,116,000Kasisomayajula Viswanath · Harvard School Of Public Health · P01 · FY2011 · TP
Center for American Indian and Rural Health Equity
$1,115,953Alexandra K Adams · Montana State University - Bozeman · P20 · FY2021 · GM
Collaborative Modeling for Assessment and Optimization in Public Health
$1,114,972Marc Lipsitch · Harvard School Of Public Health · U54 · FY2017 · GM
Collaborative Modeling for Assessment and Optimization in Public Health
$1,114,972Marc Lipsitch · Harvard School Of Public Health · U54 · FY2016 · GM
Development of a Universal Influenza Seasonal Vaccine
$1,113,078David B. Weiner · University Of Pennsylvania · R01 · FY2012 · AI
Advancing a broad-spectrum anti-influenza A virus RNA packaging inhibitor to an IND
$1,112,974Jeffrey S Glenn · Stanford University · R01 · FY2020 · AI
Viruses and Hematopoiesis
$1,112,843Neal S Young · National Heart, Lung, And Blood Institute · ZIA · FY2013 · HL
CONTROL OF EPIDEMIC INFLUENZA
$1,112,582Baylor College Of Medicine · U01 · FY2001 · AI
VACCINE ADJUVANT DISCOVERY PROGRAM (VADP)
$1,112,104Ofer Levy · Boston Children'S Hospital · N01 · FY2025 · AI